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Response: Keeping Abreast of
New Science
Sinks and Jackson take strong issue with a
recent paper in EHP by Gulson et al. (1) on
the biokinetics of lead transfer from maternal
bone and other body lead stores to nursing
infants via human breast milk. I wrote an
invited Research Highlights paper (2) that
accompanied and discussed the larger context
and implications ofGulson et al. While Sinks
andJackson did not include my paper in their
letter, their criticisms apply to a number of
issues addressed in myartide.
Sinks and Jackson would have us believe
Gulson et al. (1) were guilty of a public
health heresywhen the latter noted that there
may be potential risks for nursing infants if
lead intakes via breast milk are elevated
because of elevated long-term maternal lead
exposures. My quantitative lead exposure risk
calculations for nursing infants in Table 1
make it clear that the potential impact of
maternal lead burdens for nursing infants
across a range of maternal blood lead (BPb)
values is not atrivial matter.
The clearly indicated goals of Gulson et
al. (1) were to examine and quantitatively
characterize 1) in vivolead movement in nurs-
ing mothers, specifically bone lead resorption
during lactation and nursing, and 2) the toxi-
cokinetic interplay between endogenous
(bone) and exogenous (diet) lead in thebodies
ofthese mothers as they relate to transport of
maternal lead to breast milk and then to nurs-
ing infants. Their findings document that
bone lead releases can contribute significantly
to breast milk lead and ultimately to infant
lead intake in terms of lead source fractional
input. The breast milk study was the latest in
a published peer-reviewed series by Gulson et
al. that used the method of stable lead iso-
topic ratio analysis to quantify the contribu-
tion of bone lead to BPb and lead in other
metabolic compartments, and the temporal
character ofsuch inputs.
The findings revealed by Gulson et al.,
when examined with the many studies of
breast milk lead levels in lactating and nurs-
ing women, indicate that the toxicokinetic
parameters governing lead transfer at low
concentrations ofBPb to breast milkapply to
other cases where there were or are high
maternal lead exposures. This especially
applies to the ratio ofbreast milk lead to BPb
concentrations, which appears to increase at
higher maternal BPb levels.
Neither the Gulson et al. paper nor my
perspective article engaged in undue specula-
tion about risks to the early infant from lead
exposures arising from quite elevated breast
milk lead concentrations. A comparative
analysis ofthe many studies documenting the
quantitative ratios between maternal BPb and
associated breast milk lead levels readily
shows that 1) as BPb increases, not only does
the amount ofmilk lead increase but the frac-
tional distribution may also increase; and 2)
at high maternal lead exposures sufficient to
produce high maternal BPb levels, mothers
will have breast milk lead that may be prob-
lematic for their infants' lead exposures.
Sinks and Jackson take Gulson et al. to
task for suggesting screening of nursing
mothers, particularly those suspected of past
or present high lead exposures. This is a
peculiar criticism. That lead will enter breast
milk from maternal body lead stores in pro-
portion to the lead exposures in nursing
mothers is far from new information. New
data of Gulson et al. that show a significant
fraction of maternal lead released into breast
milk would be derived from very high bone
lead levels following maternal chronic high
lead exposures merely add a transgenerational
dimension to established phenomena. They
permit one to conclude that such maternal
exposures should be monitored. This is the
only way to identify the extent oflead releas-
es to breast milk and ultimately to infants.
The suggestion is hardly inappropriate.
Sinks andJackson cite a 1997 report from
the government's Health Resources and
Services Administration's (HRSA's) National
Center for Education in Maternal and Child
Health on the medical benefits and con-
traindications for infant breast milk feeding.
The report was authored by an authority on
the topic, Ruth A. Lawrence (3). Lawrence's
report says clearly that in the case oflikely ele-
vated lead exposures, it is advisable to not
only screen children (to presumably include
nursing infants) but to screen mothers as well.
Sinks and Jackson state that Lawrence's
report (3) identified a maternal BPb level of
40 jig/dl as the upper limit ofsafe in terms of
the amount of lead entering breast milk and
amounts of lead ingested by nursing infants.
However, the only citation in Lawrence's
report used as the basis for the ceiling figure of
40 pg/dl is a summary 1994 article in the
Centers for Disease Control and Prevention's
(CDC's) Morbidity and Mortality Weekly
Report (MMWR) on preliminary Phase 1
National Health and Nutrition Examination
Survey (NHANES) III data (4). This MMWR
artide, however, contains no discussion oflead
in breast milk and provides no evidence for
selection ofany particular infant breast-feeding
safety limit in terms ofmaternal BPb. In par-
ticular, it cannot be used to justify 40 pg/dl as
the upper limit of a safe maternal BPb for
nursing mothers. It is also clear that Lawrence
(3) is not comfortable with the use ofa mater-
nal BPb as high as 40 pg/dl. As noted,
Lawrence recommended testing nursing
infants for lead exposure even ifmaternal BPb
concentrations are below 40 pg/dl and to do
environmental lead assessments if maternal
BPb is above 10 pg/dl.
Lawrence (3) also implies that a breast
milk lead level is acceptable if such levels do
not materially add to infant lead burdens.
Specifically, not only would no net accumula-
tion occur if infant lead intake is less than 5
pg/day, but infant lead burdens acquired in
uterowould begin to show net excretion (neg-
ative lead balance) at such lowlead intakes.
Use of the high and obsolete maternal
BPb value of40 pg/dl as the upper limit for
producing safe milk lead content, even if it
were somehow still relevant, raises the obvi-
ous question of what breast milk lead level
would be associated with this maternal BPb
guideline. Lawrence (3) states that breast
milk lead content can typically range up to
15-20% ofthe maternal BPb level. This is a
range consistent with a number of breast
milk lead studies in which BPb levels were
elevated. Selection of 15% as the ratio results
in a breast milk level of60 pg/l (6 pg/dl) for
a maternal BPb of40 pg/dl.
I am not aware ofany published toxicoki-
netic analysis or any other credible quantita-
tive risk assessment of breast milk lead
intakes by nursing infants that would validate
a maternal BPb level of40 pg/dl as the upper
limit ofsafe with regard to resulting lead lev-
els in breast milk and infant BPb levels. I
have carried out an analysis of the 40 pg/dl
BPb value, as part of a series of selected
maternal BPb levels, in terms of resulting
infant BPb levels. The results are in Table 1.
Table 1 presents modeled infant exposures
using the EPA's Integrated Exposure-Uptake
Biokinetic (IEUBK) computer model for this
purpose. This well-validated model is in rou-
tine use by risk assessors (5). The modeling
results provide both geometric mean (GM)
BPb concentrations and the percentages of
these nursing infants, 0-6 months ofage, who
would exceed the CDC action level of 10
pg/dl and exceed the medical intervention,
Class III CDC risk level of 20 pg/dl. Infant
BPb mean levels in Table 1 are model-estimat-
ed from postnatal milk lead intakes plus body
lead at birth from prenatal maternal exposures.
Table 1 shows that the only "safe" level,
in terms of the fraction of infants with >20
pg/dl, would be maternal BPb of 15 pg/dl if
no more than 5% ofinfants are to exceed the
20-ig/dl figure. If the risk management
restriction is no more than 1% to exceed this
Environmental Health Perspectives * Volume 107, Number 2, February 1999 A 59Correspondence
value, a maternal BPb value of 10 pg/dl, as
seen in Table 1, should not be exceeded. If
no more than 5% of breast-feeding infants
are to exceed the 10 pg/dI action level, then a
maternal BPb <10 jig/dl is required.
A sensitivity analysis using various
IEUBK modeling runs shows that the infant
body lead burden at birth, from in utero
accumulation via maternal lead exposures, is
mainly expressed through estimated BPb val-
ues in the first 6 months of infant life, as
compared to the second 6 months of infant
life or as compared to exposure integrated
over the entire first year ofinfant life. This is
to be expected, given the relatively high bio-
kinetic mobility of lead in the very young.
However, it is precisely in the first 6 months
of infant life that breast-feeding is done.
Therefore, both breast milk lead and prior
infant body lead burden are significant
sources of lead in breast-feeding infants of
mothers with elevated lead exposures. In
essence, the only maternal BPb level that is in
fact "safe" in terms ofCDC Class III elevated
infant BPb figures also approximates the
CDC infant BPb action level of 10 pg/dl. In
terms ofthe child action level of 10 pg/dl, a
maternal BPb <10 pg/dl appears prudent.
The 1991 CDC statement on childhood
lead poisoning (6) identified a BPb level of
10 pg/dl as being the body lead threshold
associated with the earliest toxic effects in
infants and toddlers. The CDC document
also accepted the risk assessment premise that
there is no known threshold for lead's subtle
toxicity.
Sinks and Jackson argue that the most
recent NHANES III, 1991-1994, indicates
that there are no women in the United States
who are likely to be nursing their infants and
who have BPb values anywhere dose to the 40
pg/dl Sinks and Jackson daimed as permissible
for nursing mothers. They cite some actual
numbers noted in the NHANES III data
tapes (7). Such prevalence data are aggregated
cluster sample depictions at a single time
point of the U.S. population lead exposure
picture, stratified by national socioeconomic
and demographic strata. One cannot legiti-
mately disaggregate such national depictions
or "snapshots" to generate comparisons for
individual community prevalences or to use
actual BPb values contained in any particular
statistical sampling cell in the aggregation
process. Such limits are discussed in, among
other things, the Executive Summary of the
1988 report to the U.S. Congress on child-
hood lead poisoning (8) by the Agency for
Toxic Substances and Disease Registry.
Sinks and Jackson offer the simplistic and
incorrect argument that if women in the
United States were nursing their infants and
had elevated BPbs from workplace exposures,
they would be readily and reliably detected by
Occupational Safety and Health Administra-
tion (OSHA)-required exposure and medical
surveillance. Many small operations are either
exempt from OSHA requirements because of
size or are rarely if ever inspected because of
severe resource constraints on federal or vari-
ous state OSHA agencies. Such assessments
similarly would not detect the women who
potentially have elevated BPb values owing to
environmental, not occupational, lead expo-
sures. A much better approach, regardless of
sources ofhigh maternal exposure, would be
the approach endorsed by Lawrence (3):
maternal/infant screening.
The letter by Sinks and Jackson may be
seen by some as another example ofan overall
CDC retreat from lead as a persisting child
health issue. Needleman (9) noted an overall
backpedaling in efforts and dedine in momen-
tum to finally address the lead issue in a mean-
ingful way by the federal government. All this
raises a legitimate question among scientists
and clinicians interested in lead: Is lead still
considered to be a child health risk issue at the
CDC orelsewhere in the federal government?
The actual content of new research
should be understood before wholesale
attacks on such research are launched. This is
especially the case where complex research
designs and equally complex results are at
work. In those cases where breast milk does
not contain worrisome lead concentrations
Table 1. Predicted blood lead (BPb) levels in breast-feeding infants atvarious maternal BPb levelsa
Maternal nursing Infant Pb GM infant BPb
BPb (pgIdi)b intake (pg/day)c (pgIdl)d % >10pg/d1e % >20pg/dif
40 48 19.4 90.7 45.1
30 36 15.4 78.4 26.9
20 24 11.3 58.3 10.6
15 18 9.1 40.4 4.4
10 12 6.9 19.8 1.0
GM, geometric mean.
°EPA's Integrated Exposure-Uptake Biokinetic Model,Version O.99d; input parameters were milk Pb uptake = 50%; 0 ml tapwater; milk Pb =
1100% diet+fluid Pb; model defaultdust/soil inputs for0-12-month-old infants.
bBreast milkfeeding period, 0-6 months ofage; matemal BPb levels are present at birththrough 6 months.
cInfant Pbintake/day =0.15x maternal BPb(pg/dl) x8dl milk/day.
dGeometric standarddeviation = 1.6; GM infant BPb and percentages exceeding cutoffs obtained from graphic outputs expressed as
probability density function histograms versus infant BPb and using age band WA 10-6 months ofage).
eCDCaction level of210pg/dl.
fCDC Class Ill, medicalintervention level of.20 pg/dl.
from high maternal lead exposures, per Table
1, I agree with the Sinks and Jackson com-
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Response to Sinks and
Jackson
We appreciate Sinks' andJackson's interest in
our article on lead in breast milk and would
like to reinforce and clarify a couple of
points. Paul Mushak has responded compre-
hensively to their letter, and we are in com-
plete agreement with his response.
We agree wholeheartedly that "breast is
best," and our low concentrations of lead in
breast milk confirm this. Our abstract (1)
was quite emphatic that
Breast-fed infants are only at risk ifthe moth-
er is exposed to high concentrations ofconta-
minants either from endogenous sources such
as the skeleton orexogenous sources.
Sinks and Jackson are dismissive of the
use of lead isotopic ratios as not being
"meaningful in establishing risk for lead poi-
soning." Perhaps this is true in the strict sense
ofrisk assessment, but lead isotopic ratios are
the only realistic method of determining the
source ofa mother's lead burden.
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